Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans

Abstract Lead exposure can cause substantial organ damage. Enteral lead absorption may be reduced by concomitant intake of clinoptilolite tuff, a zeolite from natural sources. This study aimed to assess the effect of purified clinoptilolite tuff (G-PUR) on enteral lead uptake in adults using stable...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karolina Samekova, Christa Firbas, Johanna Irrgeher, Christine Opper, Thomas Prohaska, Anika Retzmann, Cornelius Tschegg, Claudia Meisslitzer, Anastassiya Tchaikovsky, Ghazaleh Gouya, Michael Freissmuth, Michael Wolzt
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e3ed057f9f0f42f99db1388f0e83ac53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e3ed057f9f0f42f99db1388f0e83ac53
record_format dspace
spelling oai:doaj.org-article:e3ed057f9f0f42f99db1388f0e83ac532021-12-02T17:57:16ZConcomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans10.1038/s41598-021-94245-x2045-2322https://doaj.org/article/e3ed057f9f0f42f99db1388f0e83ac532021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94245-xhttps://doaj.org/toc/2045-2322Abstract Lead exposure can cause substantial organ damage. Enteral lead absorption may be reduced by concomitant intake of clinoptilolite tuff, a zeolite from natural sources. This study aimed to assess the effect of purified clinoptilolite tuff (G-PUR) on enteral lead uptake in adults using stable lead isotope 204Pb as a tracer. In this randomized, placebo-controlled, double-blind, parallel-group study, 42 healthy participants were randomized to receive oral G-PUR 2.0 g, 2 * 2.0 g, or placebo, together with 2.5 µg of 204Pb in water. The enrichment of 204Pb caused by the tracer in blood and urine was measured by mass spectrometry. G-PUR was well tolerated. The mean maximum 204Pb enrichment of 0.505% of total blood lead was significantly higher (p < 0.0001) in the placebo group compared to G-PUR 2.0 g (0.073%) or G-PUR 2 * 2.0 g (0.057%) group. Normalized 204Pb AUC0-192 was 86.5, 11.9, and 8.5% * h without and with G-PUR 2.0 g, and G-PUR 2 * 2.0 g, respectively (p < 0.0001 vs. placebo). This smaller 204Pb exposure was paralleled by a reduced urinary excretion in subjects receiving G-PUR. Concomitant oral intake of purified clinoptilolite tuff reduced enteral uptake of 204Pb in healthy humans by approximately 90%. The reduced bioavailability is demonstrable by a decrease of 204Pb tracer enrichment in blood and urine. Trial registration: clinicaltrials.gov identifier: NCT04138693, registered 24/10/2019.Karolina SamekovaChrista FirbasJohanna IrrgeherChristine OpperThomas ProhaskaAnika RetzmannCornelius TscheggClaudia MeisslitzerAnastassiya TchaikovskyGhazaleh GouyaMichael FreissmuthMichael WolztNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Karolina Samekova
Christa Firbas
Johanna Irrgeher
Christine Opper
Thomas Prohaska
Anika Retzmann
Cornelius Tschegg
Claudia Meisslitzer
Anastassiya Tchaikovsky
Ghazaleh Gouya
Michael Freissmuth
Michael Wolzt
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
description Abstract Lead exposure can cause substantial organ damage. Enteral lead absorption may be reduced by concomitant intake of clinoptilolite tuff, a zeolite from natural sources. This study aimed to assess the effect of purified clinoptilolite tuff (G-PUR) on enteral lead uptake in adults using stable lead isotope 204Pb as a tracer. In this randomized, placebo-controlled, double-blind, parallel-group study, 42 healthy participants were randomized to receive oral G-PUR 2.0 g, 2 * 2.0 g, or placebo, together with 2.5 µg of 204Pb in water. The enrichment of 204Pb caused by the tracer in blood and urine was measured by mass spectrometry. G-PUR was well tolerated. The mean maximum 204Pb enrichment of 0.505% of total blood lead was significantly higher (p < 0.0001) in the placebo group compared to G-PUR 2.0 g (0.073%) or G-PUR 2 * 2.0 g (0.057%) group. Normalized 204Pb AUC0-192 was 86.5, 11.9, and 8.5% * h without and with G-PUR 2.0 g, and G-PUR 2 * 2.0 g, respectively (p < 0.0001 vs. placebo). This smaller 204Pb exposure was paralleled by a reduced urinary excretion in subjects receiving G-PUR. Concomitant oral intake of purified clinoptilolite tuff reduced enteral uptake of 204Pb in healthy humans by approximately 90%. The reduced bioavailability is demonstrable by a decrease of 204Pb tracer enrichment in blood and urine. Trial registration: clinicaltrials.gov identifier: NCT04138693, registered 24/10/2019.
format article
author Karolina Samekova
Christa Firbas
Johanna Irrgeher
Christine Opper
Thomas Prohaska
Anika Retzmann
Cornelius Tschegg
Claudia Meisslitzer
Anastassiya Tchaikovsky
Ghazaleh Gouya
Michael Freissmuth
Michael Wolzt
author_facet Karolina Samekova
Christa Firbas
Johanna Irrgeher
Christine Opper
Thomas Prohaska
Anika Retzmann
Cornelius Tschegg
Claudia Meisslitzer
Anastassiya Tchaikovsky
Ghazaleh Gouya
Michael Freissmuth
Michael Wolzt
author_sort Karolina Samekova
title Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
title_short Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
title_full Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
title_fullStr Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
title_full_unstemmed Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
title_sort concomitant oral intake of purified clinoptilolite tuff (g-pur) reduces enteral lead uptake in healthy humans
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e3ed057f9f0f42f99db1388f0e83ac53
work_keys_str_mv AT karolinasamekova concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT christafirbas concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT johannairrgeher concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT christineopper concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT thomasprohaska concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT anikaretzmann concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT corneliustschegg concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT claudiameisslitzer concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT anastassiyatchaikovsky concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT ghazalehgouya concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT michaelfreissmuth concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
AT michaelwolzt concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans
_version_ 1718379080821243904